Catalyst Wire Dossier Catalyst Wire Dossier

Prulacabtagene Leucel (Prula-cel)

Prulacabtagene Leucel · Adicet Therapeutics
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Prulacabtagene Leucel (Prula-cel), covering 2026-03-19 to 2026-03-19. Get the full timeline:

Most recent: Clinical Trial Update: A Phase 1 Study of Prulacabtagene Leucel (Prula-cel, Formerly ADI-001) in Autoimmune Disease [Phase 1]

See pricing